Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
33 studies found for:    Open Studies | "Adrenal Hyperplasia, Congenital"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Adrenal Hyperplasia, Congenital"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Adrenocortical Functions in Women With Nonclassical 21-hydroxylase Deficiency.
Conditions: Adrenal Hyperplasia, Congenital;   21-hydroxylase Deficiency
Intervention: Other: Functional explorations
2 Unknown  Role of the Protein Osteoprotegerin in the Bone Health of Women With Congenital Adrenal Hyperplasia
Condition: Adrenal Hyperplasia, Congenital
Intervention:
3 Unknown  Determining the Long-Term Effects of Prenatal Dexamethasone Treatment in Children With 21-Hydroxylase Deficiency and Their Mothers
Condition: Adrenal Hyperplasia, Congenital
Intervention:
4 Recruiting A Study of ATR-101 for the Treatment of Congenital Adrenal Hyperplasia
Condition: Congenital Adrenal Hyperplasia
Intervention: Drug: ATR-101
5 Recruiting COrticosteroid in Congenital Adrenal Hyperplasia
Condition: Congenital Adrenal Hyperplasia
Interventions: Biological: Hormonal balance measurements;   Biological: metabolic balance measurements;   Biological: bone balance measurements;   Behavioral: quality of life assessment
6 Not yet recruiting Androgen Reduction in Congenital Adrenal Hyperplasia, Phase 1
Condition: Congenital Adrenal Hyperplasia
Intervention: Drug: Abiraterone acetate
7 Recruiting Comparison of Chronocort® With Standard Glucocorticoid Therapy in Patients With Congenital Adrenal Hyperplasia
Condition: Congenital Adrenal Hyperplasia
Interventions: Drug: Chronocort®;   Drug: standard glucocorticoid therapy
8 Not yet recruiting Prenatal Dex Study
Condition: Congenital Adrenal Hyperplasia
Intervention: Behavioral: Neuropsychological and cognitive assessment
9 Unknown  Tweens to Teens Project at Penn State
Condition: Congenital Adrenal Hyperplasia
Intervention: Behavioral: Questionnaires/Interviews
10 Unknown  Mutation Analysis of 17α-Hydroxylase
Conditions: Pseudohermaphroditism;   Congenital Adrenal Hyperplasia;   Hypertension
Intervention: Procedure: blood drawing
11 Recruiting Mutations of Glucocorticoid Receptor in Bilateral Adrenal Hyperplasia
Condition: General Glucocorticoid Resistance
Intervention: Genetic: blood collection for mutation characterization
12 Recruiting Extension Study for Patients Entered Into Study Infacort 003
Condition: Adrenal Insufficiency
Intervention: Drug: Infacort®
13 Recruiting Acupuncture or Metformin for Insulin Resistance in Women With PCOS
Conditions: Polycystic Ovary Syndrome;   Insulin Resistance;   Hyperandrogenism
Interventions: Other: Lifestyle management;   Device: Acupuncture;   Drug: Metformin
14 Recruiting Urinary DENND1A.V2 as a Predictor of Pubertal Hyperandrogenemia
Conditions: Polycystic Ovary Syndrome;   Hyperandrogenism;   Puberty
Intervention: Other: Phenotype/genotype assessment
15 Recruiting Phlebotomy and Polycystic Ovary Syndrome
Conditions: Hyperandrogenism;   Metabolic Cardiovascular Syndrome
Interventions: Procedure: Phlebotomy;   Drug: ethinylestradiol;   Drug: Cyproterone Acetate
16 Not yet recruiting Ultrasound Three-dimensional Characterization of Ovarian Morphology in Women With Polycystic Ovary Syndrome (PCOS)
Conditions: PCOS;   Hyperandrogenism
Interventions: Procedure: Ultrasound;   Procedure: Determination of concentrations of androgens;   Device: Three dimensional ultrasound probe
17 Recruiting Assessment of Day-night Secretion of Progesterone and LH Across Puberty
Conditions: Puberty;   Hyperandrogenism
Intervention: Other: Blood sampling
18 Unknown  Hemocoagulation and Lipoperoxidation in Women Using Combined Oral Contraceptives, Correction by Antioxidants
Conditions: Polycystic Ovarian Syndrome;   Hyperandrogenism;   Menstrual Irregularities
Interventions: Drug: 20 mcg ethinylestradiol /3 mg drospirenone;   Drug: 20 mcg ethinylestradiol/3 mg drospirenone and Selmevit;   Drug: 30 mcg ethinylestradiol/3 mg drospirenone;   Drug: 30 mcg ethinylestradiol/3 mg drospirenone and Selmevit;   Drug: 35 mcg ethinylestradiol/2 mg cyproterone;   Drug: 35 mcg ethinylestradiol/2 mg cyproterone and Selmevit
19 Recruiting Androgen Excess as a Mechanism for Adipogenic Dysfunction in PCOS Women
Condition: Polycystic Ovary Syndrome (PCOS)
Interventions: Drug: Flutamide;   Other: Placebo
20 Unknown  Meal Timing on Glucose and Hyperandrogenism in PCOS Women
Condition: Polycystic Ovary Syndrome (PCOS) Women
Interventions: Behavioral: Placebo Comparator: Lifestyle counseling Dinner Diet ARM 2;   Other: Active Comparator: Lifestyle counseling ARM 1

   Previous Page Studies Shown (1-20) Next Page (21-33) Show next page of results    Last Page
Indicates status has not been verified in more than two years